Suvretta Capital Management’s Ambrx Biopharma, Inc. Common Stock AMAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,491,832
| Closed | -$1.61M | – | 109 |
|
|
2022
Q3 | $1.61M | Hold |
1,491,832
| – | – | 0.07% | 66 |
|
|
2022
Q2 | $3.95M | Hold |
1,491,832
| – | – | 0.15% | 69 |
|
|
2022
Q1 | $6.15M | Buy |
1,491,832
+434,097
| +41% | +$1.79M | 0.19% | 60 |
|
|
2021
Q4 | $9.55M | Buy |
+1,057,735
| New | +$9.55M | 0.18% | 63 |
|
|
2021
Q3 | – | Sell |
-1,169,529
| Closed | -$22.9M | – | 134 |
|
|
2021
Q2 | $22.9M | Buy |
+1,169,529
| New | +$22.9M | 0.34% | 58 |
|